| |
|
|
|
Clovis Oncology Inc  
|
|
4.76 0.32 (0.07%) |
11-27 13:00 |
|
Open: |
4.55 |
Pre close: |
4.44 |
Target:
|
5.95 
|
|
High: |
4.82 |
Low: |
4.5227 |
Resistance:
|
5.09
5.72
|
|
Volume: |
4,494,214 |
Market Cap: |
492M |
Support:
|
4.08
3.39
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.40
 |
MACD |
MACD(12,26):
|
-0.25 |
|
MA(20): |
4.48 |
Signal(12,26,9): |
-0.33 |
|
MA(100): |
5.59 |
Stochastic Oscillator |
%K(14,3):
|
53.95 |
|
MA(250): |
7.18 |
%D(3): |
30.31 |
|
Average Volume(K) |
3-Month: |
467092
|
52-Week |
High:
|
15.55 |
|
10-Days: |
414352 |
Low: |
3.62 |
|
RSI |
RSI(14):
|
50.96 |
Change(%): |
-71.0 |
|
Financials, Statistics and Valuation |
|
EPS |
-5.008 |
Return on Equity (ttm) |
0.0 |
Shares Out. (M) |
88.20 |
|
EPS Est. Current Year |
-7.580 |
Return on Assets (ttm) |
-31.4 |
Shares Float (M) |
85.17 |
|
EPS Est. Next Year |
-2.460 |
PEG Ratio |
0.00 |
% Held by Insiders |
2.05 |
|
EPS Est. Next Quarter |
-1.150 |
Qtrly Rev. Growth |
3.1 |
% Held by Institutions |
58.33 |
|
Forward EPS |
-7.430 |
Gross Profit (p.s.) |
1.282 |
Shares Short (K) |
40650 |
|
Book Value (p.s.) |
-1.850 |
EBITDA (p.s.) |
-3.636 |
P/E |
-0.95 |
|
Sales Per Share |
1.820 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-2.57 |
|
Profit Margin |
-230.33 |
Operating Cash Flow
(M) |
-266.82 |
P/S |
2.62 |
|
Operating Margin |
-204.86 |
Levered Free Cash Flow
(M) |
-130.38 |
P/CF |
-1.57 |
|
|
|
|
|
|
